IL17A and psoriasis: Interestingly, 17-β-estradiol treatment in C57BL/6 OVX mice was shown to modulate γδ T cells, a major source of IL-17 (54) and in the imiquimod-induced psoriasis model, estrogen aggravated the disease by enhancing IL-23 secretion from dendritic cells (42).